Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models

Documenti analoghi

• Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
  di: Weir, Genevieve M, et al.
  Pubblicazione: (2014)
• Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide
  di: Weir, Genevieve M., et al.
  Pubblicazione: (2016)
• Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo
  di: Weir, Genevieve M., et al.
  Pubblicazione: (2017)
• Therapeutic vaccines and cancer: focus on DPX-0907
  di: Karkada, Mohan, et al.
  Pubblicazione: (2014)
• Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model
  di: Dirk, Brennan S., et al.
  Pubblicazione: (2021)